[F]3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile ([F]F-MTEB) is a radioligand developed for positron emission tomography (PET) imaging of metabotropic glutamate receptor subtype 5 (mGlu5) in the central nervous system (CNS) (1). Glutamate is a major excitatory neurotransmitter at CNS synapses. Many neuroanatomical CNS projection pathways contain glutamatergic neurons (2). Glutamate produces its excitatory effects by acting on cell-surface ionotropic glutamate or metabotropic glutamate (mGlu) receptors (3). The mGlu receptors are G-protein-coupled receptors, and the eight mGlu receptor subtypes are further subdivided into groups I, II, and III. The group I receptors include mGlu1 and mGlu5, and they are found mostly in postsynaptic locations. The mGlu5 receptors are found with high to moderate density in the frontal cortex, caudate, putamen, nucleus accumbens, olfactory tubercle, hippocampus, and dorsal horn of the spinal cord, whereas the density in the cerebellum is low. These receptors are coupled to phospholipase C and up- or down-regulate neuronal excitability. They have been implicated in a variety of diseases in the CNS, including anxiety, depression, schizophrenia, Parkinson’s disease, and drug addiction or withdrawal. These receptors are also involved in the modulation of various pain states. They thus are attractive targets for therapeutic drug development. PET and single-photon emission tomography of radioligands targeting mGlu5 receptors can visualize and study the CNS mGlu5 receptors in normal and pathologic states. Some mGlu5 antagonists have been successfully labeled, but their in visualization has been hampered by high lipophilicity, unfavorable brain uptake kinetics, or a high metabolism (4, 5). 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP) have been identified as potent and highly selective noncompetitive antagonists for mGlu5 receptors. Using the structure of MTEP as a template, Hamill et al. (1) and Patel et al (5). designed several MTEP analogs as PET radiotracers, and [F]F-MTEB was one of the compounds that showed high affinity for mGlu5 receptors with moderate lipophilicity.
[F]3-氟-5-[(2-甲基-1,3-噻唑-4-基)乙炔基]苯甲腈([F]F-MTEB)是一种开发用于正电子发射断层扫描(PET)成像中枢神经系统(CNS)中代谢型谷氨酸受体5(mGlu5)的放射性配体(1)。谷氨酸是中枢神经系统突触中的主要兴奋性神经递质。许多神经解剖学上的中枢神经系统投射通路都含有谷氨酸能神经元(2)。谷氨酸通过作用于细胞表面离子型谷氨酸或代谢型谷氨酸(mGlu)受体产生其兴奋作用(3)。mGlu受体是G蛋白偶联受体,8种mGlu受体亚型进一步细分为I、II和III组。I组受体包括mGlu1和mGlu5,它们大多位于突触后位置。mGlu5受体在额叶皮质、尾状核、壳核、伏隔核、嗅结节、海马体和脊髓背角中以高到中等密度存在,而在小脑中的密度较低。这些受体与磷脂酶C偶联,上调或下调神经元兴奋性。它们与中枢神经系统中的多种疾病有关,包括焦虑、抑郁、精神分裂症、帕金森病以及药物成瘾或戒断。这些受体也参与各种疼痛状态的调节。因此,它们是治疗药物开发的有吸引力的靶点。针对mGlu5受体的放射性配体的PET和单光子发射断层扫描可以在正常和病理状态下可视化和研究中枢神经系统mGlu5受体。一些mGlu5拮抗剂已成功标记,但它们的可视化受到高亲脂性、不利的脑摄取动力学或高代谢的阻碍(4,5)。2-甲基-6-(苯乙炔基)吡啶(MPEP)和3-[(2-甲基-1,3-噻唑-4-基)乙炔基]吡啶(MTEP)已被确定为mGlu5受体的强效和高度选择性非竞争性拮抗剂。以MTEP的结构为模板,哈米尔等人(1)和帕特尔等人(5)设计了几种MTEP类似物作为PET放射性示踪剂,[F]F-MTEB是对mGlu5受体具有高亲和力且亲脂性适中的化合物之一。